IL15 and cancer: In this first clinical trial, an administration of recombinant IL-15 clearing lung cancer lesions in metastatic cancer patients astatic further supports the effectiveness of immune checkpoint molecules in NK cells as target cancer immunotherapy.255 Combined therapy is emerging more effective strategy for treating cancer.